Curti antonio
Università degli Studi di Bologna
H-index: 45
Europe-Italy
Top articles of Curti antonio
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort | American Journal of Hematology | Carmelo Gurnari Maria Rosaria Pascale Antonio Vitale Elisa Diral Alessandro Tomelleri | 2024/2 |
Deciphering signaling pathways in hematopoietic stem cells: The molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression | Irene Casalin Alessia De Stefano Eleonora Ceneri Alessandra Cappellini Carlo Finelli | 2024/1/12 | |
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells | Stem Cells | Valentina Pensato Maria Antonella Laginestra Paolo Falvo Stefania Orecchioni Giovanna Talarico | 2024/1/1 |
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood | Alessia De Stefano Alessandra Cappellini Irene Casalin Stefania Paolini Sarah Parisi | 2024/3/14 | |
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion | Cell Reports | Barbara Bassani Giorgia Simonetti Valeria Cancila Antonio Fiorino Marilena Ciciarello | 2024/2/27 |
Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study) | Leukemia Research Reports | Maria Paola Martelli Nicola Di Renzo Antonio Curti Nicola Stefano Fracchiolla Luca Maurillo | 2024/2/23 |
Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec)(Ven-Dec) for Elderly (≥ 60< 75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML … | Blood | Domenico Russo Nicola Polverelli Stella Santarone Francesco Onida Luca Castagna | 2023/11/28 |
Abstract CT025: NMS-03592088, a novel, potent FLT3, KIT and CSF1R inhibitor with activity in FLT3 positive acute myeloid leukemia patients with prior FLT3 inhibitor experience | Cancer Research | Antonio Curti Alessandro Rambaldi Chiara Cattaneo Roberto Cairoli Matteo Della Porta | 2023/4/14 |
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study | British Journal of Haematology | Darina Ocadlikova Federico Lussana Nicola Fracchiolla Massimiliano Bonifacio Lidia Santoro | 2023/11 |
P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE | HemaSphere | Carmelo Gurnari Maria Rosaria Pascale Antonio Vitale Elisa Diral Alessandro Tomelleri | 2023/8/1 |
PB1792: REPURPOSING OF ANTIBIOTICS INHIBITING MITOCHONDRIAL TRANSLATION IN COMBINATION WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA: FROM PRECLINICAL MODELS TO CLINICAL PRACTICE | HemaSphere | Viviana Amato Stefania Fusani Cristina Papayannidis Jacopo Nanni Antonio Curti | 2023/8/1 |
Iron-Related Laboratory Profile May Predict Response and MRD Negativity Rate in Acute Myeloid Leukemia Patients | Blood | Federico Zingarelli Gianluca Cristiano Chiara Sartor Letizia Zannoni Jacopo Nanni | 2023/11/28 |
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia | Blood | Dorian Forte Filippo Maltoni Samantha Bruno Paulina Garcia-Gonzalez Gianluca Cristiano | 2023/11/28 |
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK … | Frontiers in Immunology | Raffaella Meazza Loredana Ruggeri Fabio Guolo Paola Minetto Paolo Canevali | 2023/2/14 |
Blinatumomab and inotuzumab ozogamicin sequential use for the treatment of relapsed/refractory acute lymphoblastic leukemia: a real-life campus all study | Cancers | Nicola Stefano Fracchiolla Mariarita Sciumè Cristina Papayannidis Antonella Vitale Sabina Chiaretti | 2023/9/19 |
P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES-PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL | HemaSphere | Giovanni Marconi Shukaib Arslan Shaun Fleming Antonio Curti James S Blachly | 2023/8/1 |
P1375: VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS | HemaSphere | Darina Ocadlikova Giulia Corradi Dorian Forte Gianluca Cristiano Michele Cavo | 2023/8/1 |
Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial | Blood | Shukaib Arslan Giovanni Marconi Giovanni Martinelli Shaun Fleming Antonio Curti | 2023/11/28 |
Bone Marrow Microenvironment As a Potential Key Regulator of Hematopoietic Cells Stemness in Myelodysplastic Syndromes (MDS) | Blood | Irene Casalin Alessia De Stefano Alessandra Cappellini Eleonora Ceneri Martina Lops | 2023/11/28 |
Molecular profiling of PLCs and cytokine secretion after PLCB1 modulation in hematopoietic cells and bone marrow microenvironment. | Italian Journal of Anatomy & Embryology/Archivio Italiano di Anatomia Ed Embriologia | Irene Casalin Alessia De Stefano Alessandra Cappellini Antonio Curti Stefania Paolini | 2023/1/2 |
